Premier Explosives Limited (PREMEXPLN)
Earnings Call Transcript
AI summary
- Q1 FY27 revenue declined 28% y-y to INR102.6 Cr due to dispatch and project delays
- EBIT fell 80% y-y to INR4.8 Cr; EBIT margin 4.7%; PAT down 80% y-y to INR3 Cr; PAT margin 3%
- Order book at INR1,393 Cr with 94% from Defense segment
- FY27 revenue guidance maintained at INR600 Cr despite weak start
- EBITDA margin target remains 15-20% for FY27; raw material costs pressured Q1 margins
- Export licenses backlog being cleared; export revenue target INR150-200 Cr in Q2 FY27
- Capex progress: RDX/HMX plant water trials expected Sep 2026; mixer plant commissioning by end Sep
- Apollo Micro Systems acquisition to enhance defense electronics capabilities and growth
- Multiple analyst queries on export licenses, order execution, and margin recovery
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 PREMEXPLN — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add PREMEXPLN to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Premier Explosives Limited
Important.
The summary above is generated automatically from Premier Explosives Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.